Exact Mass: 525.2456
Exact Mass Matches: 525.2456
Found 500 metabolites which its exact mass value is equals to given mass value 525.2456
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mikamycin A
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D025361 - Streptogramins Virginiamycin M1 (Pristinamycin IIA; Ostreogrycin A), produced by?Streptomyces virginiae, is an polyunsaturated macrocyclic lactone antibiotic and acts as a component of Virginiamycin (HY-112665)[1]. Virginiamycin M1 alone is against Staphylococcus aureus with a MIC of 0.25 μg/mL. The combination of Virginiamycin M1 and Virginiamycin S1 (HY-N6680) is 0.125 μg/mL (MIC Value), which can improve the bactericidal effect 1-30 times[2].
virginiamycin m1
Selpercatinib
Chondrochloren A
A monocarboxylic acid amide with formula C27H40ClNO7, that is produced by Chondromyces crocatus and exhibits antibiotic properties.
Tyr Ser Glu Lys
His Val Arg Asp
2-[2-(3,4-Dimethoxy-phenyl)-ethyl]-6-(4-methoxy-phenyl)-2,3,6,7,12,12a-hexahydro-pyrazino[1,2:1,6]pyrido[3,4-b]indole-1,4-dione
Cys Glu Phe Lys
Cys Glu Lys Phe
Cys Phe Glu Lys
Cys Phe Lys Glu
Cys Phe Arg Thr
Cys Phe Thr Arg
Cys Ile Lys Tyr
Cys Ile Gln Tyr
Cys Ile Tyr Lys
Cys Ile Tyr Gln
Cys Lys Glu Phe
Cys Lys Phe Glu
Cys Lys Ile Tyr
Cys Lys Leu Tyr
Cys Lys Tyr Ile
Cys Lys Tyr Leu
Cys Leu Lys Tyr
Cys Leu Gln Tyr
Cys Leu Tyr Lys
Cys Leu Tyr Gln
Cys Gln Ile Tyr
Cys Gln Leu Tyr
Cys Gln Tyr Ile
Cys Gln Tyr Leu
Cys Arg Phe Thr
Cys Arg Thr Phe
Cys Thr Phe Arg
Cys Thr Arg Phe
Cys Tyr Ile Lys
Cys Tyr Ile Gln
Cys Tyr Lys Ile
Cys Tyr Lys Leu
Cys Tyr Leu Lys
Cys Tyr Leu Gln
Cys Tyr Gln Ile
Cys Tyr Gln Leu
Asp His Arg Val
Asp His Val Arg
Asp Lys Thr Tyr
Asp Lys Tyr Thr
Asp Arg His Val
Asp Thr Lys Tyr
Asp Thr Tyr Lys
Asp Tyr Lys Thr
Asp Tyr Thr Lys
Glu Cys Phe Lys
Glu Cys Lys Phe
Glu Phe Cys Lys
Glu Phe Lys Cys
Glu His Ile Gln
Glu His Leu Gln
Glu His Gln Ile
Glu His Gln Leu
Glu Ile His Gln
Glu Ile Gln His
Glu Lys Cys Phe
Glu Lys Phe Cys
Glu Lys Ser Tyr
Glu Lys Tyr Ser
Glu Leu His Gln
Glu Leu Gln His
Glu Gln His Ile
Glu Gln His Leu
Glu Gln Ile His
Glu Gln Leu His
Glu Ser Lys Tyr
Glu Ser Tyr Lys
Glu Tyr Lys Ser
Glu Tyr Ser Lys
Phe Cys Glu Lys
Phe Cys Lys Glu
Phe Cys Arg Thr
Phe Cys Thr Arg
Phe Glu Cys Lys
Phe Glu Lys Cys
Phe Phe Asn Val
Phe Phe Val Asn
Phe Lys Cys Glu
Phe Lys Glu Cys
Phe Lys Met Thr
Phe Lys Thr Met
Phe Met Lys Thr
Phe Met Gln Thr
Phe Met Thr Lys
Phe Met Thr Gln
Phe Asn Phe Val
Phe Asn Val Phe
Phe Gln Met Thr
Phe Gln Thr Met
Phe Arg Cys Thr
Phe Arg Thr Cys
Phe Thr Cys Arg
Phe Thr Lys Met
Phe Thr Met Lys
Phe Thr Met Gln
Phe Thr Gln Met
Phe Thr Arg Cys
Phe Val Phe Asn
Phe Val Asn Phe
Gly Met Arg Tyr
Gly Met Tyr Arg
Gly Arg Met Tyr
Gly Arg Tyr Met
Gly Tyr Met Arg
Gly Tyr Arg Met
His Glu Ile Gln
His Glu Leu Gln
His Glu Gln Ile
His Glu Gln Leu
His Ile Glu Gln
His Ile Gln Glu
His Leu Glu Gln
His Leu Gln Glu
His Asn Gln Gln
His Pro Ser Trp
His Pro Trp Ser
His Gln Glu Ile
His Gln Glu Leu
His Gln Ile Glu
His Gln Leu Glu
His Gln Asn Gln
His Gln Gln Asn
His Ser Pro Trp
His Ser Trp Pro
His Trp Pro Ser
His Trp Ser Pro
Ile Cys Lys Tyr
Ile Cys Gln Tyr
Ile Cys Tyr Lys
Ile Cys Tyr Gln
Ile Glu His Gln
Ile Glu Gln His
Ile His Glu Gln
Ile His Gln Glu
Ile Lys Cys Tyr
Ile Lys Tyr Cys
Ile Gln Cys Tyr
Ile Gln Glu His
Ile Gln His Glu
Ile Gln Tyr Cys
Ile Tyr Cys Lys
Ile Tyr Cys Gln
Ile Tyr Lys Cys
Ile Tyr Gln Cys
Lys Cys Glu Phe
Lys Cys Phe Glu
Lys Cys Ile Tyr
Lys Cys Leu Tyr
Lys Cys Tyr Ile
Lys Cys Tyr Leu
Lys Asp Thr Tyr
Lys Asp Tyr Thr
Lys Glu Cys Phe
Lys Glu Phe Cys
Lys Glu Ser Tyr
Lys Glu Tyr Ser
Lys Phe Cys Glu
Lys Phe Glu Cys
Lys Phe Met Thr
Lys Phe Thr Met
Lys Ile Cys Tyr
Lys Ile Tyr Cys
Lys Leu Cys Tyr
Lys Leu Tyr Cys
Lys Met Phe Thr
Lys Met Thr Phe
Lys Ser Glu Tyr
Lys Ser Tyr Glu
Lys Thr Asp Tyr
Lys Thr Phe Met
Lys Thr Met Phe
Lys Thr Tyr Asp
Lys Tyr Cys Ile
Lys Tyr Cys Leu
Lys Tyr Asp Thr
Lys Tyr Glu Ser
Lys Tyr Ile Cys
Lys Tyr Leu Cys
Lys Tyr Ser Glu
Lys Tyr Thr Asp
Leu Cys Lys Tyr
Leu Cys Gln Tyr
Leu Cys Tyr Lys
Leu Cys Tyr Gln
Leu Glu His Gln
Leu Glu Gln His
Leu His Glu Gln
Leu His Gln Glu
Leu Lys Cys Tyr
Leu Lys Tyr Cys
Leu Gln Cys Tyr
Leu Gln Glu His
Leu Gln His Glu
Leu Gln Tyr Cys
Leu Tyr Cys Lys
Leu Tyr Cys Gln
Leu Tyr Lys Cys
Leu Tyr Gln Cys
Met Phe Lys Thr
Met Phe Gln Thr
Met Phe Thr Lys
Met Phe Thr Gln
Met Gly Arg Tyr
Met Gly Tyr Arg
Met Lys Phe Thr
Met Lys Thr Phe
Met Asn Val Tyr
Met Asn Tyr Val
Met Gln Phe Thr
Met Gln Thr Phe
Met Arg Gly Tyr
Met Arg Tyr Gly
Met Thr Phe Lys
Met Thr Phe Gln
Met Thr Lys Phe
Met Thr Gln Phe
Met Val Asn Tyr
Met Val Tyr Asn
Met Tyr Gly Arg
Met Tyr Asn Val
Met Tyr Arg Gly
Met Tyr Val Asn
Asn Phe Phe Val
Asn Phe Val Phe
Asn His Gln Gln
Asn Met Val Tyr
Asn Met Tyr Val
Asn Gln His Gln
Asn Gln Gln His
Asn Val Phe Phe
Asn Val Met Tyr
Asn Val Tyr Met
Asn Tyr Met Val
Asn Tyr Val Met
Pro His Ser Trp
Pro His Trp Ser
Pro Ser His Trp
Pro Ser Trp His
Pro Trp His Ser
Pro Trp Ser His
Gln Cys Ile Tyr
Gln Cys Leu Tyr
Gln Cys Tyr Ile
Gln Cys Tyr Leu
Gln Glu His Ile
Gln Glu His Leu
Gln Glu Ile His
Gln Glu Leu His
Gln Phe Met Thr
Gln Phe Thr Met
Gln His Glu Ile
Gln His Glu Leu
Gln His Ile Glu
Gln His Leu Glu
Gln His Asn Gln
Gln His Gln Asn
Gln Ile Cys Tyr
Gln Ile Glu His
Gln Ile His Glu
Gln Ile Tyr Cys
Gln Leu Cys Tyr
Gln Leu Glu His
Gln Leu His Glu
Gln Leu Tyr Cys
Gln Met Phe Thr
Gln Met Thr Phe
Gln Asn His Gln
Gln Asn Gln His
Gln Gln His Asn
Gln Gln Asn His
Gln Thr Phe Met
Gln Thr Met Phe
Gln Tyr Cys Ile
Gln Tyr Cys Leu
Gln Tyr Ile Cys
Gln Tyr Leu Cys
Arg Cys Phe Thr
Arg Cys Thr Phe
Arg Phe Cys Thr
Arg Phe Thr Cys
Arg Gly Met Tyr
Arg Gly Tyr Met
Arg Met Gly Tyr
Arg Met Tyr Gly
Arg Ser Thr Tyr
Arg Ser Tyr Thr
Arg Thr Cys Phe
Arg Thr Phe Cys
Arg Thr Ser Tyr
Arg Thr Tyr Ser
Arg Tyr Gly Met
Arg Tyr Met Gly
Arg Tyr Ser Thr
Arg Tyr Thr Ser
Ser Glu Lys Tyr
Ser Glu Tyr Lys
Ser His Pro Trp
Ser His Trp Pro
Ser Lys Glu Tyr
Ser Lys Tyr Glu
Ser Pro His Trp
Ser Pro Trp His
Ser Arg Thr Tyr
Ser Arg Tyr Thr
Ser Thr Arg Tyr
Ser Thr Tyr Arg
Ser Trp His Pro
Ser Trp Pro His
Ser Tyr Glu Lys
Ser Tyr Lys Glu
Ser Tyr Arg Thr
Ser Tyr Thr Arg
Thr Cys Phe Arg
Thr Cys Arg Phe
Thr Asp Lys Tyr
Thr Asp Tyr Lys
Thr Phe Cys Arg
Thr Phe Lys Met
Thr Phe Met Lys
Thr Phe Met Gln
Thr Phe Gln Met
Thr Phe Arg Cys
Thr Lys Asp Tyr
Thr Lys Phe Met
Thr Lys Met Phe
Thr Lys Tyr Asp
Thr Met Phe Lys
Thr Met Phe Gln
Thr Met Lys Phe
Thr Met Gln Phe
Thr Gln Phe Met
Thr Gln Met Phe
Thr Arg Cys Phe
Thr Arg Phe Cys
Thr Arg Ser Tyr
Thr Arg Tyr Ser
Thr Ser Arg Tyr
Thr Ser Tyr Arg
Thr Tyr Asp Lys
Thr Tyr Lys Asp
Thr Tyr Arg Ser
Thr Tyr Ser Arg
Val Phe Phe Asn
Val Phe Asn Phe
Val Met Asn Tyr
Val Met Tyr Asn
Val Asn Phe Phe
Val Asn Met Tyr
Val Asn Tyr Met
Val Tyr Met Asn
Val Tyr Asn Met
Trp His Pro Ser
Trp His Ser Pro
Trp Pro His Ser
Trp Pro Ser His
Trp Ser His Pro
Trp Ser Pro His
Tyr Cys Ile Lys
Tyr Cys Ile Gln
Tyr Cys Lys Ile
Tyr Cys Lys Leu
Tyr Cys Leu Lys
Tyr Cys Leu Gln
Tyr Cys Gln Ile
Tyr Cys Gln Leu
Tyr Asp Lys Thr
Tyr Asp Thr Lys
Tyr Glu Lys Ser
Tyr Glu Ser Lys
Tyr Gly Met Arg
Tyr Gly Arg Met
Tyr Ile Cys Lys
Tyr Ile Cys Gln
Tyr Ile Lys Cys
Tyr Ile Gln Cys
Tyr Lys Cys Ile
Tyr Lys Cys Leu
Tyr Lys Asp Thr
Tyr Lys Glu Ser
Tyr Lys Ile Cys
Tyr Lys Leu Cys
Tyr Lys Ser Glu
Tyr Lys Thr Asp
Tyr Leu Cys Lys
Tyr Leu Cys Gln
Tyr Leu Lys Cys
Tyr Leu Gln Cys
Tyr Met Gly Arg
Tyr Met Asn Val
Tyr Met Arg Gly
Tyr Met Val Asn
Tyr Asn Met Val
Tyr Asn Val Met
Tyr Gln Cys Ile
Tyr Gln Cys Leu
Tyr Gln Ile Cys
Tyr Gln Leu Cys
Tyr Arg Gly Met
Tyr Arg Met Gly
Tyr Arg Ser Thr
Tyr Arg Thr Ser
Tyr Ser Lys Glu
Tyr Ser Arg Thr
Tyr Ser Thr Arg
Tyr Thr Asp Lys
Tyr Thr Lys Asp
Tyr Thr Arg Ser
Tyr Thr Ser Arg
Tyr Val Met Asn
Tyr Val Asn Met
Pentoxyverine Citrate
C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents Pentoxyverine (Carbetapentane) citrate is an orally active sigma-1 receptor agonist, with Kis of 41 nM, 894 nM and 75 nM for σ1, σ2 and guinea-pig brain membrane σ1, respectively. Pentoxyverine citrate is a muscarinic antagonist. Pentoxyverine citrate is a potent antitussive, anticonvulsant, and spasmolytic agent. Pentoxyverine citrate can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4].
3,5-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)guanosine
N-(9,9-dimethyl-9H-fluoren-2-yl)-9,9-diphenyl-9H-fluoren-2-amine
N2-[(Phenylmethyl)sulfonyl]-D-arginyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-formylbutyl]glycinamide
(2S,3S,5S)-5-(tert-Butoxycarbonylamino)-2-(N-5-thiazolylmethoxycarbonyl)amino-1,6-diphenyl-3-hydroxyhexane
Sonolisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Selpercatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Deptropine citrate
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists
N-[4-[[5-[3-(2-furanylmethyl)-4-oxo-1,2-dihydroquinazolin-2-yl]-2-methoxyphenyl]methoxy]-3,5-dimethylphenyl]acetamide
Virginiamycin M1
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D025361 - Streptogramins C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic Virginiamycin M1 (Pristinamycin IIA; Ostreogrycin A), produced by?Streptomyces virginiae, is an polyunsaturated macrocyclic lactone antibiotic and acts as a component of Virginiamycin (HY-112665)[1]. Virginiamycin M1 alone is against Staphylococcus aureus with a MIC of 0.25 μg/mL. The combination of Virginiamycin M1 and Virginiamycin S1 (HY-N6680) is 0.125 μg/mL (MIC Value), which can improve the bactericidal effect 1-30 times[2].
[(1-{2[(4-Carbamimidoyl-phenylamino)-methyl]-1-methyl-1H-benzoimidazol-5-YL}-cyclopropyl)-pyridin-2-YL-methyleneaminooxy]-acetic acid ethyl ester
(E,3R,8S,9S,10R)-N-[(Z)-2-(3-chloro-4-hydroxyphenyl)ethenyl]-3,9-dihydroxy-2,4-dimethoxy-6,8,10-trimethyl-7-oxotetradec-5-enamide
[(6Z)-6-[[bis(prop-2-enyl)amino]methylidene]-5-hydroxy-9-(methoxymethyl)-9a,11a-dimethyl-1,4,7-trioxo-2,3,3a,9,10,11-hexahydroindeno[4,5-h]isochromen-10-yl] acetate
2-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)anilino]-5,11-dimethyl-6-pyrimido[4,5-b][1,4]benzodiazepinone
N-[2,5-diethoxy-4-(4-morpholinyl)phenyl]-4-[(3,5-dimethyl-4-isoxazolyl)methoxy]-3-methoxybenzamide
(12aS)-2-(3,4-dimethoxyphenethyl)-6-(4-methoxyphenyl)-2,3,12,12a-tetrahydropyrazino[1,2:1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione
N-[(2S,4aR,12aR)-2-[2-[(1,3-dimethylpyrazol-4-yl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(5R,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(2S,4aR,12aS)-2-[2-[(1,3-dimethylpyrazol-4-yl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
(2S)-2-[(4S,5S)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5R)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5S)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(5R,6S,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(2R,4aR,12aS)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
(2S)-2-[(4R,5R)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5R)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(5S,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(5S,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(5S,6S,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(5R,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(2S,4aS,12aS)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aS,12aR)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aR,12aR)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aS,12aR)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aS,12aS)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
Pristinamycin IIA
A macrolide that is (together with pristinamycin IA) a component of pristinamycin, an oral streptogramin antibiotic produced by Streptomyces pristinaespiralis. Pristinamycin exhibits bactericidal activity against Gram positive organisms including methicillin-resistant Staphylococcus aureus.